IV Acetylcysteine Provides Rapid Protocol to Prevent Contrast-Induced Renal Dysfunction
Tuesday, 08 July 2003
NEW YORK (Reuters Health) - In patients undergoing cardiac catheterization, intravenous acetylcysteine provides a rapid and effective protocol for the prevention of radiocontrast-induced nephropathy (RCIN) when time constraints preclude adequate prophylaxis the day before with oral saline hydration.
read more
|
Renal Insufficiency Without Albuminuria, Retinopathy Common in Type 2 Diabetics
Wednesday, 25 June 2003
NEW YORK (Reuters Health) - A substantial number of adults with type 2 diabetes have chronic renal insufficiency without albuminuria or retinopathy, researchers report.
read more
|
Nonselective Screening of Hypertensives Yields High-Rate of Primary Aldosteronism
Thursday, 19 June 2003
NEW YORK (Reuters Health) - Evidence continues to mount that primary aldosteronism (PAL), a potentially curable form of hypertension, is much more common than once believed, justifying screening of all hypertensive patients, not just those with hypokalemia, a researcher said at a major meeting of endocrinologists on Thursday.
read more
|
Theophylline is Safe and Effective for Contrast-Induced Nephropathy
Thursday, 05 June 2003
NEW YORK (Reuters Health) - Theophylline is a safe and effective treatment for contrast-induced nephropathy (CIN) in high-risk patients with chronic renal insufficiency undergoing coronary angiography, according to a report in the May 15th issue of the American Journal of Cardiology.
read more
|
Reasons for the Unabated Rise in Kidney Failure in the US Remain Unresolved
Thursday, 29 May 2003
NEW YORK (Reuters Health) - Over the past two decades, the incidence of treated end-stage renal disease (ESRD) in the US has risen at an annual rate of 8%.
read more
|
Deficiency of Filtration Protein May Increase Risk of Glomerular Disease
Thursday, 22 May 2003
NEW YORK (Reuters Health) - Findings from a new study suggest that a shortage of CD2-assoicated protein (CD2AP), a component of the renal filtration complex, may increase susceptibility to glomerular disease.
read more
|
High-dose ACE Inhibitor Therapy Unlikely to Improve Renoprotection
Monday, 07 October 2002
NEW YORK (Reuters Health) - The antihypertensive effect of angiotensin-converting enzyme (ACE) inhibitors is closely related to their antiproteinuric effect, study results show.
read more
|
Mild to Moderate Renal Disease Increases Mortality Risk After MI
Monday, 30 September 2002
NEW YORK (Reuters Health) - End-stage renal disease has been linked with reduced survival after myocardial infarction (MI). But findings from two new studies now indicate that even mild to moderate renal dysfunction is associated with an increased risk of death following MI.
read more
|
Mortality of Chronic Renal Disease Tied to Timing and Frequency of Nephrologist Care
Wednesday, 25 September 2002
NEW YORK (Reuters Health) - The mortality rate of chronic renal insufficiency during the first year of dialysis appears to be influenced by when and how often a patient had visited a nephrologist before starting dialysis, according to a report published in the September 23rd issue of the Archives of Internal Medicine.
read more
|
Post-MI Drug Regimen Beneficial for Renal Disease Patients, but Underused
Wednesday, 25 September 2002
NEW YORK (Reuters Health) - Patients with kidney disease who have experienced a myocardial infarction (MI) may benefit from aspirin plus beta-blocker (ASA + BB) therapy nearly as much as other patients do, but receive such treatment less often, according to a recent report.
read more
|
Timing of Nephrologist Evaluation Impacts Survival in End-stage Renal Disease
Friday, 20 September 2002
NEW YORK (Reuters Health) - The timing of the first evaluation by a nephrologist appears to have a significant impact on outcome in patients with end-stage renal disease, with late evaluation associated with shortened survival, greater disease burden and more comorbidity.
read more
|
Hemofiltration Recommended for Infection-associated Renal Failure in Developing Countries
Thursday, 19 September 2002
NEW YORK (Reuters Health) - Researchers recommend hemofiltration over peritoneal dialysis in developing countries because it reduces mortality and is more cost-effective, according to a report published in the September 19th issue of The New England Journal of Medicine.
read more
|
Excess Risk of Kidney Disease Among Blacks Largely Unexplained
Wednesday, 04 September 2002
NEW YORK (Reuters Health) - African Americans are known to be at higher risk for chronic kidney disease (CKD) than whites.
read more
|
High-normal Albuminuria Increases Renal Insufficiency Risk in Hypertensive Men
Wednesday, 24 July 2002
NEW YORK (Reuters Health) - In men with uncomplicated essential hypertension, high-normal albuminuria is associated with a more adverse cardiovascular and metabolic risk profile compared with that of hypertensive men with albuminuria of less than 9 µg/minute. According to a group of Italian physicians, this profile may put these men at risk for glomerular hypertension and renal insufficiency.
read more
|
Laparoscopic Adrenalectomy Safe and Effective for Pheochromocytomas
Friday, 21 June 2002
NEW YORK (Reuters Health) - Most patients with familial pheochromocytomas can be safe and effectively managed with a laparoscopic approach to their adrenal disease, according to a recent report.
read more
|
Adrenal and Retroperitoneum 
